Global Medical Net Worth
Global Medical Net Worth Breakdown | GMRE |
Global Medical Net Worth Analysis
Global Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Global Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Global Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Global Medical's net worth analysis. One common approach is to calculate Global Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Global Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Global Medical's net worth. This approach calculates the present value of Global Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Global Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Global Medical's net worth. This involves comparing Global Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Global Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if Global Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Global Medical's net worth research are outlined below:
| Global Medical REIT has a strong financial position based on the latest SEC filings | |
| About 60.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: GMRE or CDP Which Is the Better Value Stock Right Now |
Global Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Global Medical REIT. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Global Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Global Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Global Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Global Medical REIT backward and forwards among themselves. Global Medical's institutional investor refers to the entity that pools money to purchase Global Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Charles Schwab Investment Management Inc | 2024-06-30 | 811.9 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 682.7 K | Phocas Financial Corp | 2024-06-30 | 669.6 K | Pacific Ridge Capital Partners, Llc | 2024-06-30 | 598.1 K | State Of New Jersey Common Pension Fd D | 2024-06-30 | 590.3 K | Northern Trust Corp | 2024-06-30 | 556 K | Keeley-teton Advisors, Llc | 2024-06-30 | 471.9 K | Davidson D A & Co | 2024-06-30 | 437.5 K | Cutler Capital Management | 2024-06-30 | 435.9 K | Vanguard Group Inc | 2024-06-30 | 6.2 M | Blackrock Inc | 2024-06-30 | 5.3 M |
Follow Global Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 665.77 M.Market Cap |
|
Project Global Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.02 | 0.02 | |
| Return On Capital Employed | 0.08 | 0.09 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.04 | 0.03 |
When accessing Global Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Global Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Global Medical's profitability and make more informed investment decisions.
Please note, the presentation of Global Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Global Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Global Medical's management manipulating its earnings.
Evaluate Global Medical's management efficiency
Global Medical REIT has return on total asset (ROA) of 0.0174 % which means that it generated a profit of $0.0174 on every $100 spent on assets. This is way below average. Global Medical's management efficiency ratios could be used to measure how well Global Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Global Medical's Return On Capital Employed is projected to slightly grow based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.02, whereas Return On Equity is forecasted to decline to 0.03. At present, Global Medical's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 71.9 M, whereas Total Current Assets are forecasted to decline to about 13.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 9.24 | 12.97 | |
| Tangible Book Value Per Share | 8.15 | 11.67 | |
| Enterprise Value Over EBITDA | 12.04 | 7.82 | |
| Price Book Value Ratio | 1.25 | 2.13 | |
| Enterprise Value Multiple | 12.04 | 7.82 | |
| Price Fair Value | 1.25 | 2.13 | |
| Enterprise Value | 18 M | 18.9 M |
The analysis of Global Medical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Global Medical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Global Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Enterprise Value Revenue 9.8172 | Revenue 137.8 M | Quarterly Revenue Growth (0.06) | Revenue Per Share 2.102 | Return On Equity 0.0094 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Global Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Global Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Global Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ronald Marston over a month ago Acquisition by Ronald Marston of 9316 shares of Global Medical subject to Rule 16b-3 | ||
Roscoe Moore over six months ago Acquisition by Roscoe Moore of 5000 shares of Global Medical subject to Rule 16b-3 | ||
Robert Kiernan over six months ago Acquisition by Robert Kiernan of 27434 shares of Global Medical subject to Rule 16b-3 | ||
Robert Kiernan over six months ago Acquisition by Robert Kiernan of 38860 shares of Global Medical subject to Rule 16b-3 | ||
Jamie Barber over six months ago Acquisition by Jamie Barber of 20725 shares of Global Medical subject to Rule 16b-3 | ||
Zh Usa Llc over a year ago Purchase by Zh Usa Llc of tradable shares of Global Medical | ||
Robert Kiernan over a year ago Acquisition by Robert Kiernan of 27422 shares of Global Medical subject to Rule 16b-3 |
Global Medical Corporate Filings
8K | 17th of September 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 12th of August 2024 Other Reports | ViewVerify | |
10Q | 7th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 6th of June 2024 An amendment to a previously filed Form 8-K | ViewVerify |
Global Medical Earnings per Share Projection vs Actual
Global Medical Corporate Directors
| Henry Cole | Lead Independent Director | Profile | |
| Matthew Cypher | Independent Director | Profile | |
| Huiqi Zhang | Director | Profile | |
| Roscoe Moore | Independent Director | Profile |
Additional Information and Resources on Investing in Global Stock
When determining whether Global Medical REIT is a strong investment it is important to analyze Global Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Global Medical's future performance. For an informed investment choice regarding Global Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Dividend Share 0.84 | Revenue Per Share 2.102 | Quarterly Revenue Growth (0.06) | Return On Assets 0.0174 | Return On Equity 0.0094 |
The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.